These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 7466310)
1. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests. Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310 [TBL] [Abstract][Full Text] [Related]
2. Platelets in myeloproliferative disorders. II. Serotonin uptake and storage: correlations with mepacrine labelled dense bodies and with platelet density. Caranobe C; Sie P; Nouvel C; Laurent G; Pris J; Boneu B Scand J Haematol; 1980 Oct; 25(4):289-95. PubMed ID: 7209398 [TBL] [Abstract][Full Text] [Related]
3. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy. Ryningen A; Apelseth T; Hausken T; Bruserud Ø Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601 [TBL] [Abstract][Full Text] [Related]
4. Simultaneous study of platelets and phagocytes in myeloproliferative disorders. Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727 [TBL] [Abstract][Full Text] [Related]
5. Template bleeding time and clinical hemorrhage in myeloproliferative disease. Murphy S; Davis JL; Walsh PN; Gardner FH Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084 [TBL] [Abstract][Full Text] [Related]
6. [ATP and ADP of platelets in chronic myeloproliferative disorders and multiple myeloma]. Terada H; Ohshima M Rinsho Ketsueki; 1989 Jan; 30(1):22-8. PubMed ID: 2716195 [TBL] [Abstract][Full Text] [Related]
7. Platelet function in patients with high platelet counts. Ginsburg AD Ann Intern Med; 1975 Apr; 82(4):506-11. PubMed ID: 1054537 [TBL] [Abstract][Full Text] [Related]
8. [Aggregative behavior and calcium content of platelets in thrombocythemia and thrombocytosis]. Hochhaus A; Mindner K; Ostermann G; Höche D Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):765-70. PubMed ID: 1713878 [TBL] [Abstract][Full Text] [Related]
12. Abnormalities of epinephrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders. Yamamoto K; Sekiguchi E; Takatani O Thromb Haemost; 1984 Dec; 52(3):292-6. PubMed ID: 6531753 [TBL] [Abstract][Full Text] [Related]
13. Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis--features of significance for the diagnosis of primary (essential) thrombocythaemia. Thiele J; Schneider G; Hoeppner B; Wienhold S; Zankovich R; Fischer R Virchows Arch A Pathol Anat Histopathol; 1988; 413(5):407-17. PubMed ID: 3140482 [TBL] [Abstract][Full Text] [Related]
14. In vitro platelet aggregation defects in patients with myeloproliferative disorders and high platelet counts: are they laboratory artefacts? Grignani C; Noris P; Tinelli C; Barosi G; Balduini CL Platelets; 2009 Mar; 20(2):131-4. PubMed ID: 19235056 [TBL] [Abstract][Full Text] [Related]
15. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569 [TBL] [Abstract][Full Text] [Related]
16. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis. Mindner K; Ostermann G; Hochhaus A; Höche D; Till U Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953 [TBL] [Abstract][Full Text] [Related]
17. A review of myeloproliferative disease with presentation in the head and neck region. Collins A Ann R Australas Coll Dent Surg; 1998 Oct; 14():119-24. PubMed ID: 10895623 [TBL] [Abstract][Full Text] [Related]
18. Platelet-rich plasma serotonin levels in chronic myeloproliferative disorders: evaluation of diagnostic use and comparison with the neutrophil PRV-1 assay. Koch CA; Lasho TL; Tefferi A Br J Haematol; 2004 Oct; 127(1):34-9. PubMed ID: 15384975 [TBL] [Abstract][Full Text] [Related]
19. Platelet function studies in myeloproliferative disorders. Pfliegler G; Boda Z; Udvardy M; Kiss A; Telek B; Pecze K; Nagy P; Rak K Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):655-62. PubMed ID: 2435631 [TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications. Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]